Results 191 to 200 of about 475,202 (310)

Universal methylprednisolone pulses for the induction therapy of lupus nephritis: why not? [PDF]

Lupus Sci Med
Ruiz-Irastorza G.
europepmc   +1 more source

Dysregulation of U12‐Type Splicing in Lupus Neutrophils

Arthritis &Rheumatology, EarlyView.
Objective Neutrophil dysfunction is a hallmark of systemic lupus erythematosus (SLE), but its molecular basis remains unclear. This study explores transcriptional and posttranscriptional changes in low‐density granulocytes (LDGs), a proinflammatory neutrophil subset expanded in SLE, focusing on NADPH oxidase (Nox) function and minor intron splicing ...
Luz P. Blanco, Binod Regmi, Carmelo Carmona‐Rivera, Yudong Liu, Xiantao Wang, Philip M. Carlucci, Monica M. Jackson, Zerai Manna, Sarfaraz Hasni, Markus Hafner, Hong‐Wei Sun, Mariana J. Kaplan   +11 more
wiley   +1 more source

'Getting comfortable with the uncomfortable': barriers, facilitators and influences on reproductive health discussions from Hispanic women with systemic lupus erythematosus in the USA - a qualitative study. [PDF]

Lupus Sci Med
Delgado M, Montes De Oca A, Ramirez A, Withers M, Amezcua L, Weisman M, Wise LM.   +6 more
europepmc   +1 more source

The Effect of Intranasal Niclosamide on Nasal Symptoms in Patients with Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Arthritis &Rheumatology, EarlyView.
Objective Ear, nose, and throat (ENT) manifestations are common in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV). There is an unmet need for drugs to target these manifestations. Granuloma formation is characteristic of proteinase 3 (PR3)–AAV. In a zebrafish model, niclosamide inhibits PR3‐induced granuloma formation.
Benjamin Lim, Wendi Qian, Francis Dowling, Alan Salama, Rona M Smith   +4 more
wiley   +1 more source

Palmar Cutaneous Erythematous Macules: A Case Report of an Atypical Presentation of Chilblain Lupus Erythematosus. [PDF]

Cureus
Israr Ul Haq M, Mahmood MN, Chow EY.
europepmc   +1 more source

Impact of Early Antimalarial Adherence on Future Acute Care Utilization and Cost Among Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study

Arthritis &Rheumatology, EarlyView.
Objective To assess the association between early antimalarial adherence and future acute care utilization and cost in a population‐based cohort of incident rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Methods All patients with incident RA/SLE and new antimalarial use in British Columbia, Canada, between January 1997 and March 2022
Md Rashedul Hoque, Diane Lacaille, J. Antonio Aviña‐Zubieta, Mary A. De Vera, Yi Qian, Lawrence McCandless, John M. Esdaile, Hui Xie   +7 more
wiley   +1 more source

Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review. [PDF]

RMD Open
Calvo-Río V, Secada-Gómez C, Martín Gutiérrez A, Retuerto-Guerrero M, Font J, Casafont-Solé I, Mayo-Juanatey A, Alegre Sancho JJ, Freites D, Hormigos C, Garrido Puñal N, González Arribas G, Miguélez Sanchez JR, García-Valle A, Ibañez M, Lozano Morillo F, García Manzanares Á, Sandoval-Moreno S, Cortes-Hernandez J, Palma Sanchez D, Lojo L, Cervantes Pérez EC, Collado P, Arciniega Larios C, Sala Icardo L, Labrador-Sánchez E, Peralta-Ginés C, Urionagüena Onaindia I, Plaza-Aulestia N, Medina Malone M, Gómez de Salazar JR, Corteguera M, Cebrián-Méndez L, Antón Pages FA, Lamua Riazuelo JR, Fábregas Canales MD, Alados Hernández MJ, Garijo Bufort M, Pàmies A, Sarabia de Ardanaz L, Aguirre-Del-Pino R, Cabezas Lefler JÁ, Seijas-Lopez Á, Carrasco Cubero MDC, López-Cerón Cofiño A, Ortiz-Santamaria V, Laiño Piñeiro M, Ordás Calvo C, Arconada Lopez C, Urruticoechea-Arana A, Garcia Magallon B, Acosta Alfaro AV, Leal Rodriguez S, Salido Olivares M, Lavilla Villar P, Brandy-García AM, Ros Vilamajo I, García Martos Á, Magallares Lopez BP, Sada Urmeneta G, Córdoba Martín C, Riera E, Bejerano C, Castañeda S, Blanco R.   +64 more
europepmc   +1 more source

Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A European Multicenter Study

Arthritis &Rheumatology, EarlyView.
Objective Interstitial lung disease (ILD) can occur in association with antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV‐ILD) or as an isolated entity with positive ANCA (ANCA‐ILD). However, data on the epidemiology and outcomes of these conditions remain limited.
Aglaia Chalkia, Marusa Kotnik, Timothy J. Sadler, Spyridon Katechis, Rachel Jones, Ajay Kamath, Aladdin J. Mohammad, Sara Monti, Chetan Mukhtyar, Viral Nanda, Ioannis Petrakis, Dimitrios Petras, Ashnish Sinha, Pasupathy Sivasothy, Rona Smith, Kostas Stylianou, Dimitrios Vassilopoulos, Judith Babar, David Jayne   +18 more
wiley   +1 more source

S03.1 Endothelial function in systemic lupus erythematosus patients: impact of caffeine consumption on endothelial progenitor cells survival

Lupus Science and Medicine, 2022
F Ceccarelli, C Alessandri, F Conti, C Barbati, V Orefice, E Putro, C Pirone   +6 more
doaj   +1 more source

Clinical utility and performance of anti-C1q antibodies for SLE: comparative analysis of three different assays. [PDF]

Lupus Sci Med
Gonzalez-Treviño M, Hetrick MD, Sanchez-Rodriguez A, Duarte-Garcia A, Tebo AE.   +4 more
europepmc   +1 more source